JRCT ID: jRCT2080221090
Registered date:25/05/2010
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Prophylaxis of pertussis, diphtheria, tetanus, and poliomyelitis infection. |
Date of first enrollment | 25/05/2010 |
Target sample size | 326 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : BK-4SP INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : subcutaneous injection |
Outcome(s)
Primary Outcome | Immunogenicity |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | Age: greater than 3months old ,less than 74 months old |
Exclude criteria |
Related Information
Primary Sponsor | The Research Foundation for Microbial Diseases of Osaka University, Mitsubishi Tanabe Pharma Corporation |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-101124 |
Contact
Public contact | |
Name | |
Address | 06-6877-4804 |
Telephone | |
Affiliation | The Research Foundation for Microbial Diseases of Osaka University |
Scientific contact | |
Name | |
Address | cti-inq-ml@ml.mt-pharma.co.jp |
Telephone | |
Affiliation | Mitsubishi Tanabe Pharma Corporation |